Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis.
Pseudobulbar affect: prevalence and management.
Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis.
Primary EBV-positive Hodgkin's lymphoma of the CNS under azathioprine treatment : Case report and review of the literature.
Fatigue at time of CIS is an independent predictor of a subsequent diagnosis of multiple sclerosis.
Childhood body mass index and multiple sclerosis risk: a long-term cohort study.
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges.
Region and dynamic specificities of adult neural stem cells and oligodendrocyte precursors in myelin regeneration in the mouse brain.
Update on monitoring and adverse effects of first generation disease modifying therapies and their recently approved versions in relapsing forms of multiple sclerosis.
Ipilimumab in patients with melanoma and autoimmune disease.
Presymptomatic and longitudinal neuroimaging in neurodegeneration-from snapshots to motion picture: a systematic review.
Risk factors for multiple sclerosis and associations with anti-EBV antibody titers.
Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica.
Mind the gap! Lay and medical perceptions of risks associated with the use of alternative treatment and conventional medicine.
Pío del Río Hortega and the discovery of the oligodendrocytes.
Glatiramer Acetate 40 Mg/Ml Three Times A Week for The Treatment of Relapsing Forms of Multiple Sclerosis: Potential Cost Benefits of A Regimen With Infrequent Injections Which May Minimise Switching to The Newly-Introduced First-Line and Second-Line Dise
Endothelin-B Receptor Activation in Astrocytes Regulates the Rate of Oligodendrocyte Regeneration during Remyelination.
Impact of transcranial direct current stimulation on fatigue in multiple sclerosis.
Early detection of thrombin activity in neuroinflammatory disease.
Is neuropsychological rehabilitation effective in multiple sclerosis?
Differential effects of genetic susceptibility factors in males and females with multiple sclerosis.
Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology.
Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series.
Imaging multiple sclerosis outside the brain.
The reliability and validity study of the Kinesthetic and Visual Imagery Questionnaire in individuals with Multiple Sclerosis.
Pages
« first
‹ previous
…
591
592
593
594
595
596
597
598
599
…
next ›
last »